BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 37366884)

  • 1. The Role of Immunotherapy in the Treatment of Rare Central Nervous System Tumors.
    Rodriguez A; Kamiya-Matsuoka C; Majd NK
    Curr Oncol; 2023 May; 30(6):5279-5298. PubMed ID: 37366884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Embryonal Tumors of the Central Nervous System: An Update.
    Blessing MM; Alexandrescu S
    Surg Pathol Clin; 2020 Jun; 13(2):235-247. PubMed ID: 32389264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Embryonal tumors of the central nervous system.
    Pagès M; Masliah-Planchon J; Bourdeaut F
    Curr Opin Oncol; 2020 Nov; 32(6):623-630. PubMed ID: 32890024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histopathologic and Molecular Features of Central Nervous System Embryonal Tumors for Integrated Diagnosis Reporting.
    Cole BL; Pierson CR
    Surg Pathol Clin; 2020 Dec; 13(4):783-800. PubMed ID: 33183733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Embryonal Tumors of the Central Nervous System: From the Radiologic Pathology Archives.
    Shih RY; Koeller KK
    Radiographics; 2018; 38(2):525-541. PubMed ID: 29528832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atypical Teratoid/Rhabdoid Tumor (AT/RT) Arising From Ependymoma: A Type of AT/RT Secondarily Developing From Other Primary Central Nervous System Tumors.
    Nobusawa S; Hirato J; Sugai T; Okura N; Yamazaki T; Yamada S; Ikota H; Nakazato Y; Yokoo H
    J Neuropathol Exp Neurol; 2016 Feb; 75(2):167-74. PubMed ID: 26769252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utilizing preclinical models to develop targeted therapies for rare central nervous system cancers.
    Arakaki AKS; Szulzewsky F; Gilbert MR; Gujral TS; Holland EC
    Neuro Oncol; 2021 Nov; 23(23 Suppl 5):S4-S15. PubMed ID: 34725698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary atypical teratoid/rhabdoid tumor of central nervous system in children: a clinicopathological analysis and review of literature in China.
    Yang M; Chen X; Wang N; Zhu K; Hu YZ; Zhao Y; Shu Y; Zhao ML; Gu WZ; Tang HF
    Int J Clin Exp Pathol; 2014; 7(5):2411-20. PubMed ID: 24966951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Central nervous system tumors in patients under three years of age: treatment results of a single institute.
    Varan A; Akalan N; Söylemezoğlu F; Zorlu F; Yalçin B; Akyüz C; Kutluk T; Büyükpamukçu M
    Pediatr Neurosurg; 2006; 42(2):89-94. PubMed ID: 16465077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiation of Outcomes by Treatment Regimen and Histology in Central Nervous System Primary Embryonal Tumors.
    Bhimani AD; Ryoo JS; Reddy AK; Denyer S; McGuire LS; Alonso M; Mehta AI
    World Neurosurg; 2020 Sep; 141():e289-e306. PubMed ID: 32434022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mouse models of CNS embryonal tumors.
    Momota H; Holland EC
    Brain Tumor Pathol; 2009; 26(2):43-50. PubMed ID: 19856214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An infantile pineal embryonal tumor showing pathological features of a CNS ganglioneuroblastoma and the methylation profiling of an atypical teratoid/rhabdoid tumor and SMARCA4 mutation.
    Fukuoka K; Nakazawa A; Hirato J; Nobusawa S; Itabashi T; Arakawa Y; Mori M; Matsushita Y; Honda S; Tanami Y; Ichimura K; Kurihara J; Koh K
    J Neuropathol Exp Neurol; 2023 Jun; 82(7):664-667. PubMed ID: 37086056
    [No Abstract]   [Full Text] [Related]  

  • 13. Intensive induction chemotherapy followed by myeloablative chemotherapy with autologous hematopoietic progenitor cell rescue for young children newly-diagnosed with central nervous system atypical teratoid/rhabdoid tumors: the Head Start III experience.
    Zaky W; Dhall G; Ji L; Haley K; Allen J; Atlas M; Bertolone S; Cornelius A; Gardner S; Patel R; Pradhan K; Shen V; Thompson S; Torkildson J; Sposto R; Finlay JL
    Pediatr Blood Cancer; 2014 Jan; 61(1):95-101. PubMed ID: 23934933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aggressive infantile embryonal tumors.
    MacDonald TJ
    J Child Neurol; 2008 Oct; 23(10):1195-204. PubMed ID: 18952586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in the diagnosis, molecular genetics, and treatment of pediatric embryonal CNS tumors.
    MacDonald TJ; Rood BR; Santi MR; Vezina G; Bingaman K; Cogen PH; Packer RJ
    Oncologist; 2003; 8(2):174-86. PubMed ID: 12697942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation and Diagnosis of Central Nervous System Embryonal Tumors (Non-Medulloblastoma).
    Cotter JA; Judkins AR
    Pediatr Dev Pathol; 2022; 25(1):34-45. PubMed ID: 35168419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atypical teratoid/rhabdoid tumors of the central nervous system.
    Reddy AT
    J Neurooncol; 2005 Dec; 75(3):309-13. PubMed ID: 16195799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extraneural metastasis in intracranial tumors in children: the experience of a single center.
    Varan A; Sari N; Akalan N; Söylemezoğlu F; Akyüz C; Kutluk T; Büyükpamukçu M
    J Neurooncol; 2006 Sep; 79(2):187-90. PubMed ID: 16645723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atypical teratoid/rhabdoid tumors of the central nervous system: clinical, radiographic and pathologic features.
    Bambakidis NC; Robinson S; Cohen M; Cohen AR
    Pediatr Neurosurg; 2002 Aug; 37(2):64-70. PubMed ID: 12145514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of osteopontin as a potential biomarker for central nervous system embryonal tumors.
    Han YP; Ma CK; Wang SQ; Enomoto A; Zhao Y; Takahashi M; Ma J
    J Neurooncol; 2014 Sep; 119(2):343-51. PubMed ID: 24879375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.